Afanat 40 mg Tablet
63,80$
54,39$
Afanat 40 mg Tablet is a targeted therapy designed for the management of advanced or metastatic non-squamous non-small cell lung cancer, serving as either a first-line treatment or a subsequent option following the failure of traditional cytotoxic chemotherapy. This medication works by inhibiting specific mutations in the epidermal growth factor receptor (EGFR), particularly exon 19 deletions and L858R substitutions, which are critical for cancer cell proliferation. It is important to note that Afanat 40 mg is not recommended for children or adolescents, as its safety and effectiveness in these populations have not been established. Patients should undergo appropriate genetic testing to confirm the presence of the necessary mutations prior to treatment initiation. As with any medication, potential side effects and drug interactions should be discussed with a healthcare professional to ensure optimal safety. Afanat can play a crucial role in personalized cancer therapy, providing hope for patients battling this aggressive form of lung cancer. Always consult your doctor for tailored advice and to determine the best treatment plan for your individual health needs.
Quantité
Active Pharmaceutical Ingredient
Uses
• Afanat 40 mg tablet is primarily utilized in the treatment of non-small cell lung cancer (NSCLC), a prevalent form of lung cancer. This medication targets cancerous cells in the lungs, helping to inhibit their growth. Patients diagnosed with NSCLC may benefit from this treatment as part of their comprehensive cancer care plan. Afanat 40 mg tablet plays a crucial role in managing the progression of this disease.
• In addition to its use in NSCLC, Afanat 40 mg tablet may be prescribed to enhance the effectiveness of other cancer therapies. By working synergistically with different treatment modalities, it can improve overall outcomes for patients. This can be particularly beneficial for those undergoing chemotherapy or radiation. The inclusion of Afanat 40 mg tablet in treatment regimens often aims to provide a more robust approach to combating lung cancer.
• Afanat 40 mg tablet is also indicated for patients who have experienced disease progression after initial treatments. It serves as a subsequent line of therapy, offering hope to individuals whose cancer has not responded to earlier interventions. The administration of Afanat 40 mg tablet in such scenarios can help in managing symptoms and extending survival. This aspect of its use underscores its importance in the ongoing battle against lung cancer.
• Healthcare providers may recommend Afanat 40 mg tablet for specific cases of advanced non-small cell lung cancer. In these situations, the medication can play a vital role in controlling tumor growth and improving patients' quality of life. The strategic use of Afanat 40 mg tablet in advanced stages reflects its significance in tailored cancer treatment plans. It exemplifies how targeted therapies can be utilized effectively in oncology.
Benefits
Afanat 40 mg Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Afanat 40 mg Strip can help to slow the progression of cancer. Afatinib Tablet 40 mg may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Afanat Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Afanat 40 mg can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Decreased appetite
• Burning sensation during urination
• Fatigue
• Ankles and feet swelling.
Common Side Effects
• Vomiting
• Diarrhoea
• Mouth sores
• Acne
• Itchiness
• Rashes
How To Use
Afanat Tablet should be taken on an empty stomach at least one hour before or two hours after a meal. Always take Afanat 40 mg exactly as directed by your doctor, including the recommended number and timing of tablets. Do not change your dose or stop this medicine without consulting your doctor. If you miss a dose, take it as soon as possible. If the next dose is scheduled within 12 hours, skip the missed dose and continue with the regular dosing regimen. It is not recommended to take two doses at the same time. If you overdose on Afanat 40 mg Tablet, contact your doctor immediately or seek medical help at the nearest hospital emergency department.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Afanat 40 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Afanat 40 mg Tablet is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Afanat 40 mg Tablet is recommended. The use of Afanat 40 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Afanat 40 mg Tablet. Afanat 40 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Afanat 40 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Afanat 40 mg Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Afanat 40 mg Tablet is recommended. The use of Afanat 40 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Afanat 40 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Afanat 40 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Afanat 40 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Afanat 40 mg.